Results 191 to 200 of about 1,861,814 (218)

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Enhancing classification accuracy in medical datasets using a hybrid distance and cluster refinement-based K-means clustering method. [PDF]

open access: yesSci Rep
Al-Khamees HAA   +7 more
europepmc   +1 more source

Phenotypic Classification of Scalp High-Frequency Oscillations in Absence Epilepsy Based on Multiple Characteristics Using K-Means Clustering. [PDF]

open access: yesBioengineering (Basel)
Maeda K   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Root mean square error or mean absolute error? Use their ratio as well

Information Sciences, 2022
Dulakshi Santhusitha Kumari Karunasingha
exaly  

Home - About - Disclaimer - Privacy